You have 9 free searches left this month | for more free features.

Tyvaso

Showing 1 - 25 of 27

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Pulmonary Hypertension, Interstitial Lung Disease, Combined Pulmonary Fibrosis and Emphysema Trial (Inhaled Treprostinil)

Available
  • Pulmonary Hypertension
  • +2 more
  • Inhaled Treprostinil
  • (no location specified)
Oct 5, 2022

Progressive Pulmonary Fibrosis, Interstitial Lung Disease Trial (Placebo, Inhaled Treprostinil, Treprostinil Ultrasonic

Not yet recruiting
  • Progressive Pulmonary Fibrosis
  • Interstitial Lung Disease
  • Placebo
  • +2 more
  • (no location specified)
Jul 5, 2023

Pulmonary Arterial Hypertension Trial in United States (Treprostinil Inhalation Powder)

Active, not recruiting
  • Pulmonary Arterial Hypertension
  • Treprostinil Inhalation Powder
  • Birmingham, Alabama
  • +18 more
Nov 2, 2022

Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease Trial in Kissimmee, Kansas City, Chesterfield (Inhaled Treprostinil,

Enrolling by invitation
  • Idiopathic Pulmonary Fibrosis
  • Interstitial Lung Disease
  • Inhaled Treprostinil
  • Treprostinil Ultrasonic Nebulizer
  • Kissimmee, Florida
  • +2 more
Jul 19, 2022

Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease Trial (Placebo, Inhaled Treprostinil, Treprostinil Ultrasonic

Not yet recruiting
  • Idiopathic Pulmonary Fibrosis
  • Interstitial Lung Disease
  • Placebo
  • +2 more
  • (no location specified)
Feb 15, 2022

Sarcoidosis, Precapillary Pulmonary Hypertension, Interstitial Lung Disease Trial in Gainesville (Inhaled Treprostinil)

Recruiting
  • Sarcoidosis
  • +2 more
  • Inhaled Treprostinil
  • Gainesville, Florida
    University of Florida, Division of Pulmonary and Critical Care M
Nov 12, 2021

Congenital Heart Disease Trial in Cincinnati (Treprostinil, Placebo)

Terminated
  • Congenital Heart Disease
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center
Jul 13, 2020

Pulmonary Arterial Hypertension Trial in Phoenix (L606 inhalation suspension)

Recruiting
  • Pulmonary Arterial Hypertension
  • L606 inhalation suspension
  • Phoenix, Arizona
    Arizona Pulmonary Specialists
Jan 26, 2022

Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease Trial in United States (Placebo, Inhaled Treprostinil, Treprostinil

Recruiting
  • Idiopathic Pulmonary Fibrosis
  • Interstitial Lung Disease
  • Placebo
  • +2 more
  • Birmingham, Alabama
  • +55 more
Aug 16, 2022

Pulmonary Arterial Hypertension Trial in Israel, United States (Beraprost Sodium 314d Modified Release Tablets, Placebo)

Completed
  • Pulmonary Arterial Hypertension
  • Beraprost Sodium 314d Modified Release Tablets
  • Placebo
  • Birmingham, Alabama
  • +74 more
Jul 20, 2020

Respiratory Distress Syndrome, Adult Trial in Chapel Hill (Treprostinil Inhalation Solution, Placebo)

Terminated
  • Respiratory Distress Syndrome, Adult
  • Treprostinil Inhalation Solution
  • Placebo
  • Chapel Hill, North Carolina
    University of North Carolina Hospitals
Sep 12, 2019

Pulmonary Vascular Disease Trial in Durham (Hyperpolarized 129Xenon gas)

Recruiting
  • Pulmonary Vascular Disease
  • Hyperpolarized 129Xenon gas
  • Durham, North Carolina
    Duke University Medical Center
Oct 3, 2022

Interstitial Lung Disease, COPD, Pulmonary Arterial Hypertension Trial in Durham (Hyperpolarized 129Xe)

Not yet recruiting
  • Interstitial Lung Disease
  • +2 more
  • Hyperpolarized 129Xe
  • Durham, North Carolina
    Duke University Medical Center
Jan 14, 2022

Pulmonary Hypertension, Interstitial Lung Disease, Combined Pulmonary Fibrosis and Emphysema Trial in Puerto Rico, United States

Completed
  • Pulmonary Hypertension
  • +2 more
  • Inhaled Treprostinil
  • Placebo
  • Birmingham, Alabama
  • +96 more
Jul 21, 2022

Pulmonary Hypertension, COPD Trial in Worldwide (Inhaled treprostinil solution, Placebo solution)

Terminated
  • Pulmonary Hypertension
  • Chronic Obstructive Pulmonary Disease
  • Inhaled treprostinil solution
  • Placebo solution
  • Birmingham, Alabama
  • +75 more
Jan 5, 2023

Pulmonary Arterial Hypertension Trial in Tucson, San Francisco, Torrance (Treprostinil)

Completed
  • Pulmonary Arterial Hypertension
  • Tucson, Arizona
  • +2 more
Aug 31, 2017

Congenital Heart Disease Trial in Los Angeles, Columbus (Remodulin)

Withdrawn
  • Congenital Heart Disease
  • Los Angeles, California
  • +1 more
Sep 19, 2017

Pulmonary Arterial Hypertension Trial in United States (UT-15C SR, Tyvaso Inhalation Solution)

Completed
  • Pulmonary Arterial Hypertension
  • UT-15C SR
  • Tyvaso Inhalation Solution
  • Birmingham, Alabama
  • +5 more
Jan 11, 2017

Hypertension, Pulmonary Trial in Stanford, Chicago (treprostinil inhalations, tadalafil)

Completed
  • Hypertension, Pulmonary
  • Stanford, California
  • +1 more
Apr 27, 2017

Pulmonary Hypertension, COPD Trial (Inhaled Treprostinil)

Withdrawn
  • Pulmonary Hypertension
  • Chronic Obstructive Pulmonary Disease
  • Inhaled Treprostinil
  • (no location specified)
Apr 7, 2017

Pulmonary Hypertension, COPD Trial in Aurora, Jacksonville (Inhaled Treprostinil Therapy)

Completed
  • Pulmonary Hypertension
  • COPD
  • Inhaled Treprostinil Therapy
  • Aurora, Colorado
  • +1 more
Jul 18, 2016

Respiratory Tract AEs in Patients Treated With Tyvaso® Compared

Completed
  • Pulmonary Arterial Hypertension
  • inhaled prostacyclin
  • +4 more
  • Birmingham, Alabama
  • +87 more
Jan 20, 2016

Pulmonary Arterial Hypertension Trial in Puerto Rico, United States

Completed
  • Pulmonary Arterial Hypertension
    • La Jolla, California
    • +51 more
    Mar 20, 2015

    Inhaled Treprostinil Sodium on Ventilation Perfusion Matching

    Terminated
    • Pulmonary Arterial Hypertension
    • Chronic Obstructive Pulmonary Disease
      • Jacksonville, Florida
      • +2 more
      May 6, 2015

      Pulmonary Hypertension Trial in Worldwide (Inhaled treprostinil, Placebo inhalation solution)

      Completed
      • Pulmonary Hypertension
      • Inhaled treprostinil
      • Placebo inhalation solution
      • Birmingham, Alabama
      • +29 more
      Jul 11, 2013